DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
E••••• I••••••••• I••
Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $57.6M
sum of BDC pieces, a lower bound
Fair value
$57.0M
99c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
4
1 on the latest quarter
Facilities
2
1 equity pieces beside them
Next maturity
Aug 31, 2027
$57.6M inside 24 months
On the tape since
Sep 30, 2021
latest Jun 30, 2026
Events
10
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $57.6M | 99c | S+625 bp | Aug 31, 2027 | 4 |
| other lien unstated | unknown | n/a | unstated | 1 |
Equity pieces beside the debt: equity ($0 fair value, 2 BDCs)
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| P••••••• C•••••• C••• | term loan first lien F•••• L••• T••• L••• | n/a | n/a | |
| P••••••• C•••••• C••• | term loan first lien F•••• L••• T••• L••• | $57.6M | $57.0M 99c | S+625 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $57.6M | $57.0M | 99c | 0 |
| Mar 31, 2026 | 2 | $57.8M | $55.7M | 96c | 1 |
| Dec 31, 2025 | 2 | $0 | $0 | n/a | 2 |
| Sep 30, 2025 | 3 | $62.8M | $57.2M | 91c | 3 |
| Jun 30, 2025 | 3 | $124M | $116M | 93c | 5 |
| Mar 31, 2025 | 3 | $62.0M | $58.9M | 95c | 2 |
| Dec 31, 2024 | 3 | $61.1M | $60.1M | 98c | 0 |
| Sep 30, 2024 | 3 | $61.3M | $61.0M | 99c | 0 |
| Jun 30, 2024 | 3 | $66.6M | $66.6M | 100c | 0 |
| Jun 14, 2024 | 2 | $0 | $0 | n/a | 0 |
| Mar 31, 2024 | 4 | $60.0M | $60.0M | 100c | 0 |
| Dec 31, 2023 | 2 | $23.7M | $23.7M | 100c | 6 |
| Sep 30, 2023 | 2 | $23.7M | $23.7M | 100c | 6 |
| Jun 30, 2023 | 2 | $23.8M | $23.8M | 100c | 6 |
| Mar 31, 2023 | 2 | $23.8M | $23.8M | 100c | 6 |
| Dec 31, 2022 | 1 | $21.0M | $20.8M | 99c | 3 |
| Sep 30, 2022 | 2 | $23.5M | $23.5M | 101c | 4 |
| Sep 30, 2021 | 1 | $19.3M | $19.3M | 101c | 1 |
What changed
- Maturity approachingAug 31, 2027
- Maturity approachingAug 31, 2027
- PIK interest appearsJun 30, 2025
- PIK interest appearsMar 31, 2025
- Maturity extended (observed)Mar 31, 2025
- PIK interest appearsMar 31, 2025
- Maturity extended (observed)Mar 31, 2025
- New lender joined a facilityJun 30, 2024
- New lender joined a facilityMar 31, 2024
- Maturity extended (observed)Mar 31, 2024
- Spread changed (observed)Dec 31, 2023
- Lender left a facilityDec 31, 2023
- Lender left a facilityDec 31, 2023
- PIK interest increasedJun 30, 2023
- Spread changed (observed)Jun 30, 2023
- Spread increasedJun 30, 2023
- Spread increasedJun 30, 2023
- PIK interest increasedJun 30, 2023
- PIK interest increasedJun 30, 2023
- Spread changed (observed)Sep 30, 2022
- New borrower on a BDC scheduleSep 30, 2021
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- EMERGEderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 4 BDCsderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it